Answers are grounded in this paper and cite their sources.
One-year treatment outcomes of dexamethasone intravitreal implant for DMO in routine clinical practice were inferior to those in the clinical trials perhaps because of fewer treatments in clinical practice.
No takes yet. Share an insight, caveat, or question.
Bhandari et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: